The Changing Incidence of <i>In situ</i> and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004

Abstract

The declines in ILC observed in our study are consistent with a decrease in cancer incidence related to a reduced use of combined hormone replacement therapy. However, other factors could also be responsible for these changes.